🇺🇸 FDA
Pipeline program

Pergolide

NIDA-08355-1

Phase 3 small_molecule completed

Quick answer

Pergolide for Cocaine-Related Disorders is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Cocaine-Related Disorders
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials